Carmignac Gestion, the Paris-based investment firm managing over €60 billion in assets, has submitted its quarterly Form 13F filing with the US Securities and Exchange Commission, detailing its US equity portfolio as of 15 June. The filing, required for institutional investment managers with over $100 million in US equities, provides a snapshot of the firm's bets on American stocks during a period of heightened market uncertainty.
According to the filing, Carmignac's top holdings include major technology names such as Microsoft, Apple, and Alphabet, alongside healthcare giants like UnitedHealth Group and Eli Lilly. The portfolio's sector allocation shows a marked tilt towards growth stocks, though adjustments from the previous quarter suggest a modest pivot towards more defensive positions. The firm increased its stake in consumer staples and reduced exposure to cyclical sectors, likely in response to persistent inflation fears and rising interest rates in the US.
The filing comes as UK investors and pension funds closely monitor the moves of large asset managers for clues on market direction. Carmignac's decision to maintain a significant overweight in US tech stocks, despite the sector's recent volatility, signals a long-term conviction in digital transformation and AI-driven growth. However, analysts caution that 13F filings are backward-looking and may not reflect current positions.
For UK-based investors with exposure to global equities, the filing underscores the importance of diversification across sectors and geographies. Carmignac's strategy highlights the ongoing appeal of US mega-cap stocks, but also the need to hedge against potential downturns through defensive allocations. The FTSE 100, which closed at 7,428 points on the filing date, has since seen modest gains, partly buoyed by similar sentiment in global markets.
Industry commentators note that while 13F filings are valuable for transparency, they should not be used as a sole basis for investment decisions. 'These disclosures are a useful tool for understanding institutional trends, but they are not a trading signal,' said one London-based analyst. 'The real value lies in observing how managers like Carmignac adapt to macroeconomic shifts over time.'
Source: SEC Form 13F filing for Carmignac Gestion, dated 15 June.